• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺肿瘤 NF-κB 信号促进 T 细胞介导的免疫监视。

Lung tumor NF-κB signaling promotes T cell-mediated immune surveillance.

机构信息

Department of Immunology, Moffitt Cancer Center, Tampa, Florida 33612, USA.

出版信息

J Clin Invest. 2013 Jun;123(6):2509-22. doi: 10.1172/JCI67250. Epub 2013 May 1.

DOI:10.1172/JCI67250
PMID:23635779
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3668836/
Abstract

NF-κB is constitutively activated in many cancer types and is a potential key mediator of tumor-associated inflammation, tumor growth, and metastasis. We investigated the role of cancer cell NF-κB activity in T cell-mediated antitumor responses. In tumors rendered immunogenic by model antigen expression or following administration of antitumor vaccines, we found that high NF-κB activity leads to tumor rejection and/or growth suppression in mice. Using a global RNA expression microarray, we demonstrated that NF-κB enhanced expression of several T cell chemokines, including Ccl2, and decreased CCL2 expression was associated with enhanced tumor growth in a mouse lung cancer model. To investigate NF-κB function in human lung tumors, we identified a gene expression signature in human lung adenocarcinoma cell lines that was associated with NF-κB activity level. In patient tumor samples, overall lung tumor NF-κB activity was strongly associated with T cell infiltration but not with cancer cell proliferation. These results therefore indicate that NF-κB activity mediates immune surveillance and promotes antitumor T cell responses in both murine and human lung cancer.

摘要

NF-κB 在许多癌症类型中持续激活,是肿瘤相关炎症、肿瘤生长和转移的潜在关键介质。我们研究了癌细胞 NF-κB 活性在 T 细胞介导的抗肿瘤反应中的作用。在通过模型抗原表达或给予抗肿瘤疫苗使肿瘤具有免疫原性的情况下,我们发现高 NF-κB 活性导致小鼠肿瘤排斥和/或生长抑制。使用全基因组 RNA 表达微阵列,我们证明 NF-κB 增强了几种 T 细胞趋化因子的表达,包括 Ccl2,而 CCL2 表达的降低与小鼠肺癌模型中肿瘤生长的增强相关。为了研究 NF-κB 在人类肺癌中的功能,我们在人类肺腺癌细胞系中鉴定了一个与 NF-κB 活性水平相关的基因表达特征。在患者肿瘤样本中,整个肺肿瘤 NF-κB 活性与 T 细胞浸润强烈相关,但与癌细胞增殖无关。因此,这些结果表明 NF-κB 活性在小鼠和人类肺癌中介导免疫监视并促进抗肿瘤 T 细胞反应。

相似文献

1
Lung tumor NF-κB signaling promotes T cell-mediated immune surveillance.肺肿瘤 NF-κB 信号促进 T 细胞介导的免疫监视。
J Clin Invest. 2013 Jun;123(6):2509-22. doi: 10.1172/JCI67250. Epub 2013 May 1.
2
Antitumor activity and immunomodulatory effects of the intraperitoneal administration of Kanglaite in vivo in Lewis lung carcinoma.康莱特腹腔给药对 Lewis 肺癌小鼠的抑瘤作用及免疫调节作用
J Ethnopharmacol. 2012 Sep 28;143(2):680-5. doi: 10.1016/j.jep.2012.07.025. Epub 2012 Jul 31.
3
Knockout of the tumor suppressor gene Gprc5a in mice leads to NF-kappaB activation in airway epithelium and promotes lung inflammation and tumorigenesis.敲除肿瘤抑制基因 Gprc5a 会导致小鼠气道上皮细胞 NF-κB 激活,促进肺部炎症和肿瘤发生。
Cancer Prev Res (Phila). 2010 Apr;3(4):424-37. doi: 10.1158/1940-6207.CAPR-10-0032. Epub 2010 Mar 30.
4
Metastasis-Associated Protein 2 Represses NF-κB to Reduce Lung Tumor Growth and Inflammation.转移相关蛋白 2 抑制 NF-κB 减少肺肿瘤生长和炎症。
Cancer Res. 2020 Oct 1;80(19):4199-4211. doi: 10.1158/0008-5472.CAN-20-1158. Epub 2020 Aug 14.
5
Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.NMI 的下调促进了人类肺腺癌的肿瘤生长,并预示着不良的预后。
Mol Cancer. 2017 Oct 12;16(1):158. doi: 10.1186/s12943-017-0705-9.
6
Esculetin Attenuates the Growth of Lung Cancer by Downregulating Wnt Targeted Genes and Suppressing NF-κB.七叶亭通过下调Wnt靶向基因和抑制核因子κB来减弱肺癌的生长。
Arch Bronconeumol (Engl Ed). 2018 Mar;54(3):128-133. doi: 10.1016/j.arbres.2017.09.005. Epub 2017 Nov 3.
7
Cutting Edge: Engineering Active IKKβ in T Cells Drives Tumor Rejection.前沿:工程化T细胞中的活性IKKβ可驱动肿瘤排斥反应。
J Immunol. 2016 Apr 1;196(7):2933-8. doi: 10.4049/jimmunol.1501144. Epub 2016 Feb 22.
8
Activation of NF-κB by SOD2 promotes the aggressiveness of lung adenocarcinoma by modulating NKX2-1-mediated IKKβ expression.SOD2 通过激活 NF-κB 促进 NKX2-1 介导的 IKKβ 表达,从而增强肺腺癌的侵袭性。
Carcinogenesis. 2013 Nov;34(11):2655-63. doi: 10.1093/carcin/bgt220. Epub 2013 Jun 19.
9
Epithelial nuclear factor-κB signaling promotes lung carcinogenesis via recruitment of regulatory T lymphocytes.上皮核因子-κB 信号通过募集调节性 T 淋巴细胞促进肺癌发生。
Oncogene. 2012 Jun 28;31(26):3164-76. doi: 10.1038/onc.2011.480. Epub 2011 Oct 17.
10
Use of bioluminescent imaging to investigate the role of nuclear factor-kappaBeta in experimental non-small cell lung cancer metastasis.利用生物发光成像技术研究核因子-κB在实验性非小细胞肺癌转移中的作用。
Clin Exp Metastasis. 2008;25(1):43-51. doi: 10.1007/s10585-007-9100-z. Epub 2007 Nov 16.

引用本文的文献

1
Epigenetic silencing of DNA sensing pathway by FOXM1 blocks stress ligand-dependent antitumor immunity and immune memory.FOXM1对DNA传感通路的表观遗传沉默阻断了应激配体依赖性抗肿瘤免疫和免疫记忆。
Nat Commun. 2025 Apr 28;16(1):3967. doi: 10.1038/s41467-025-59186-3.
2
NF-κB-mediated EAAT3 upregulation in antioxidant defense and ferroptosis sensitivity in lung cancer.NF-κB介导的肺癌中EAAT3上调在抗氧化防御和铁死亡敏感性中的作用
Cell Death Dis. 2025 Feb 22;16(1):124. doi: 10.1038/s41419-025-07453-y.
3
NF-κB signaling and the tumor microenvironment in osteosarcoma: implications for immune evasion and therapeutic resistance.骨肉瘤中的核因子-κB信号传导与肿瘤微环境:对免疫逃逸和治疗抵抗的影响
Front Immunol. 2025 Jan 30;16:1518664. doi: 10.3389/fimmu.2025.1518664. eCollection 2025.
4
Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors.对PD-L1抑制的获得性耐药增强了肿瘤中I型干扰素调节的分泌程序。
EMBO Rep. 2025 Jan;26(2):521-559. doi: 10.1038/s44319-024-00333-0. Epub 2024 Dec 11.
5
NF-κB signaling pathway in tumor microenvironment.肿瘤微环境中的 NF-κB 信号通路。
Front Immunol. 2024 Oct 18;15:1476030. doi: 10.3389/fimmu.2024.1476030. eCollection 2024.
6
-activated promotes lung adenocarcinoma progression and inhibits CD4/CD8 T-cell infiltrations by targeting signaling pathway.激活的[具体内容]通过靶向[具体信号通路]促进肺腺癌进展并抑制CD4/CD8 T细胞浸润。
Transl Lung Cancer Res. 2024 Sep 30;13(9):2116-2138. doi: 10.21037/tlcr-24-50. Epub 2024 Sep 10.
7
Aberrant cytoplasmic expression of UHRF1 restrains the MHC-I-mediated anti-tumor immune response.UHRF1 的细胞质表达异常会抑制 MHC-I 介导的抗肿瘤免疫反应。
Nat Commun. 2024 Oct 3;15(1):8569. doi: 10.1038/s41467-024-52902-5.
8
The Effect of C-Reactive Protein/Lymphocyte Ratio (CLR) on PFS in Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitors: A Novel Biomarker.C反应蛋白/淋巴细胞比值(CLR)对接受CDK4/6抑制剂治疗的转移性乳腺癌患者无进展生存期的影响:一种新型生物标志物
Breast Cancer (Dove Med Press). 2024 Jul 3;16:329-339. doi: 10.2147/BCTT.S464161. eCollection 2024.
9
Epigenomic analyses identify FOXM1 as a key regulator of anti-tumor immune response in esophageal adenocarcinoma.表观基因组分析确定FOXM1是食管腺癌抗肿瘤免疫反应的关键调节因子。
Cell Death Dis. 2024 Feb 19;15(2):152. doi: 10.1038/s41419-024-06488-x.
10
Understanding the feasibility of chemotherapeutic and immunotherapeutic targets against non-small cell lung cancers: an update of resistant responses and recent combinatorial therapies.了解针对非小细胞肺癌的化疗和免疫治疗靶点的可行性:耐药反应及近期联合治疗的最新进展
Explor Target Antitumor Ther. 2023;4(5):850-895. doi: 10.37349/etat.2023.00171. Epub 2023 Oct 10.

本文引用的文献

1
A CXCL1 paracrine network links cancer chemoresistance and metastasis.CXCL1 旁分泌网络将癌症化疗耐药和转移联系起来。
Cell. 2012 Jul 6;150(1):165-78. doi: 10.1016/j.cell.2012.04.042.
2
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.抗 PD-1 抗体在癌症中的安全性、活性和免疫相关性。
N Engl J Med. 2012 Jun 28;366(26):2443-54. doi: 10.1056/NEJMoa1200690. Epub 2012 Jun 2.
3
NF-κB hyperactivation in tumor tissues allows tumor-selective reprogramming of the chemokine microenvironment to enhance the recruitment of cytolytic T effector cells.肿瘤组织中 NF-κB 的过度激活允许对趋化因子微环境进行肿瘤选择性重编程,以增强细胞毒性 T 效应细胞的募集。
Cancer Res. 2012 Aug 1;72(15):3735-43. doi: 10.1158/0008-5472.CAN-11-4136. Epub 2012 May 16.
4
Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study.伊匹单抗联合紫杉醇和卡铂作为 IIIB/IV 期非小细胞肺癌一线治疗:一项随机、双盲、多中心 II 期研究的结果。
J Clin Oncol. 2012 Jun 10;30(17):2046-54. doi: 10.1200/JCO.2011.38.4032. Epub 2012 Apr 30.
5
Accessories to the crime: functions of cells recruited to the tumor microenvironment.肿瘤微环境中募集的细胞的功能:犯罪的帮凶。
Cancer Cell. 2012 Mar 20;21(3):309-22. doi: 10.1016/j.ccr.2012.02.022.
6
Coordinated regulation of myeloid cells by tumours.肿瘤对髓系细胞的协调调控。
Nat Rev Immunol. 2012 Mar 22;12(4):253-68. doi: 10.1038/nri3175.
7
Immune microenvironments in solid tumors: new targets for therapy.实体瘤中的免疫微环境:治疗的新靶点。
Genes Dev. 2011 Dec 15;25(24):2559-72. doi: 10.1101/gad.169029.111.
8
Prognostic and predictive value of a malignancy-risk gene signature in early-stage non-small cell lung cancer.早期非小细胞肺癌中恶性肿瘤风险基因特征的预后和预测价值。
J Natl Cancer Inst. 2011 Dec 21;103(24):1859-70. doi: 10.1093/jnci/djr420. Epub 2011 Dec 8.
9
An immune-active tumor microenvironment favors clinical response to ipilimumab.免疫激活的肿瘤微环境有利于对伊匹单抗的临床应答。
Cancer Immunol Immunother. 2012 Jul;61(7):1019-31. doi: 10.1007/s00262-011-1172-6. Epub 2011 Dec 7.
10
Crizotinib.克唑替尼
Nat Rev Drug Discov. 2011 Dec 1;10(12):897-8. doi: 10.1038/nrd3600.